Navigation Links
Risk Minimization/Mitigation in the Post-Marketing Arena, New Life Science Webinar Hosted by Xtalks
Date:10/24/2013

Toronto, Canada (PRWEB) October 24, 2013

Complex pharmacovigilance legislation in an evolving regulatory landscape have left drug makers searching for current, efficient and more meaningful solutions for their drug safety challenges especially in the post-marketing arena. Now more than ever, companies seek expert advice and customized approaches to effectively collect, manage and analyze real-world evidence.

In this presentation, PRA’s late-phase and risk management experts will examine unique strategies they have developed from years of significant first-hand experience in this area. Attendees will get industry-leading insights, tips and answers to urgent risk management-planning and drug safety questions and concerns. They will also benefit from informative best practices, lessons learned and case studies.

For more information about this event or to register, visit: http://xtalks.com/Risk-Minimization-in-the-Post-Marketing-Arena.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11257909.htm'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Going a step Further: Phase IV and Post-Marketing Observational Studies add Value to new Therapies, life Science Webinar Hosted by Xtalks
2. Pharmaceutical Companies Announce Quarterly Financial Results - Research Report on Jazz, Acadia, Arena, Santarus, and Incyte
3. Sangamo BioSciences Reports Third Quarter 2013 Financial Results
4. Bayer CropScience Introduces Specticle plus Fertilizer
5. Xtalks Life Sciences Webinar Examines the Evolving Role of Global Medical Affairs
6. inMotion’s Latest Website Unveils Innovation Square, Boston’s Premier Life Science Development
7. Polysciences Inc. to Reveal Newest Addition to Warrington, PA Campus
8. Consolidation, Patent Loses, Weak R&D Productivity Depress ITO Transactions in Life Sciences Segment: Everest Group Annual Report
9. UE LifeSciences Launches WeMustTry.com Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries
10. Drug Discovery Using Natural Products - Optimization Studies of Inhibitors of Glucan Synthesis as Anti-Fungal Agents, New Life Science Webinar Hosted by Xtalks
11. Rancho BioSciences will present the tranSMART open source platform at TM Forum’s Digital Disruption 2013, Oct 28-31, San Jose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... Sterne, Kessler, Goldstein & Fox P.L.L.C. , an intellectual ... , announced today that it has filed eleven petitions ... U.S. Patent and Trademark Office (USPTO) on behalf of ... BRLI).  These IPR petitions aim to nullify eleven patents ... patents have been asserted against GeneDx in patent infringement ...
(Date:8/18/2014)... Global HIV Infection Drug Market and Pipeline Insight ... rate of HIV infection and the number of deaths due ... positive rate across the globe. It has been estimated that ... 1.5 in 2013, with the rates for children being even ... the infection rates has been the improved access to antiretroviral ...
(Date:8/18/2014)... , August 18, 2014 ... Bioreactor Systems Market, By Application (Municipal Wastewater Treatment ... Flat Sheet and Multi Tubular), By Configuration (Internal/Submerged ... 2019", published by MarketsandMarkets, The market for membrane ... by 2019, growing at a CAGR of 15.28% ...
(Date:8/18/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: ... proprietary technologies are used to develop, manufacture and ... bio-based chemical, biopharmaceutical and industrial enzyme industries, announced ... on Form 10 with the U.S. Securities and ... http://photos.prnewswire.com/prnh/20110621/CL06708LOGO The Form ...
Breaking Biology Technology:Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4
... ON , Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences ... financial results for the second quarter of fiscal 2010, ended ... numerous global in-licensing opportunities, we proposed to merge Cytopia Limited., ... during the second quarter," said David Allan , Chairman ...
... , DENVER and NEW ORLEANS , Feb. ... worldwide developer and marketer of diagnostic test kits, and Tulane ... to combat viral hemorrhagic fever (VHF), an effort that will generate ... the life of the contract. , The National Institutes of ...
... , Feb. 8 Neurocrine Biosciences, Inc. (Nasdaq: ... Ph.D. to its Board of Directors effective immediately. He is the ... Executive Chairman of Biogen Idec, Inc. , "We are very pleased ... said Joseph A. Mollica , Ph.D., Chairman of the Board ...
Cached Biology Technology:YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors 2
(Date:8/19/2014)... study that analyzed concentrations of African dust transported ... winter and spring. These research findings offer new ... quality impacts of African dust, including the climate ... occur from increased African dust emissions in the ... (UM) Rosenstiel School of Marine and Atmospheric Science ...
(Date:8/19/2014)... This news release is available in French . ... Stand: balancing the BENEFITS and RISKS of physical activity ... a stand on the promotion of childhood physical activity ... Applied Physiology, Nutrition, and Metabolism ( APNM ... of knowledge in the area of risk of physical ...
(Date:8/19/2014)... , August 19, 2014 ... / Digital Wallet Choices as latest developments, ad campaigns ... Inc. (NASDAQ: EBAY ), Amazon.com Inc. (NASDAQ: ... AAPL ), Google Inc. (NASDAQ: GOOG ) ... (OTCQB: NXTD) a biometric authentication company focused on the ...
Breaking Biology News(10 mins):Study of African dust transport to South America reveals air quality impacts 2Taking a stand: Balancing the BENEFITS and RISKS of physical activity in children 2Taking a stand: Balancing the BENEFITS and RISKS of physical activity in children 3Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 2Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 3Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 4Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 5Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 6Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 7
... discovered that very small chemical changes to dietary flavonoids cause ... for their impact on the human immune system., Plants are ... an average leaf for example, produces around 20,000. Many ... are already known to have medicinal properties with effects on ...
... and government, industry and health professionals will gather in ... the research supporting the health benefits of mushrooms ... produce aisle and often thought of as a vegetable ... The Mushrooms and Health Summit, held at the ...
... cholesterol levels and reducing the risks of cardiovascular disease, but ... The FASEB Journal suggests that they may extend ... which telomeres shorten, a key factor in the natural aging ... of statins, as an anti-aging therapy. "By telomerase activation, ...
Cached Biology News:Little changes -- large effects 2World's scientists, researchers and nutrition experts convene to explore the benefits of mushrooms 2
...
RayBio L Series 507: RayBio Label-based Antibody Array I (2 membranes) Class: Antibody Array Products Product Group: Antibody Array...
Human HVEM/TNFRSF14 Allophycocyanin MAb (Clone 94801)...
... Point Osmometer for 10 L sample. ... including pediatric, neonatal, geriatric, general adult, ... Calibration with 2 or 3 user-selected ... and software for statistical analysis and ...
Biology Products: